Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
American Journal of Hematology
|
May 20, 2011
Laboratory testing for cryoglobulins
Gabriela Motyckova, Mandakolathur Murali
Hematology/Oncology Clinics of North America
|
April 3, 2012
Why does my patient have lymphadenopathy or splenomegaly?
Gabriela Motyckova, David P Steensma
Current Treatment Options in Oncology
|
September 9, 2011
Treatment of elderly acute myeloid leukemia patients
Gabriela Motyckova, Richard M Stone
Current Molecular Medicine
|
July 20, 2002
Pycnodysostosis: role and regulation of cathepsin K in osteoclast function and human disease
Gabriela Motyckova, David E Fisher
Current Hematologic Malignancy Reports
|
April 29, 2010
The role of molecular tests in acute myelogenous leukemia treatment decisions
Gabriela Motyckova, Richard M Stone
Infection Control and Hospital Epidemiology
|
July 21, 2017
Decrease in Vancomycin-Resistant Enterococcus Colonization After Extensive Renovation of a Unit Dedicated to the Treatment of Hematologic Malignancies and Hematopoietic Stem-Cell Transplantation
Clyde D Ford, Michaela A Gazdik Stofer, Jana Coombs, et al.
British Journal of Haematology
|
January 21, 2020
Disseminated toxoplasmosis and haemophagocytic lymphohistiocytosis following chimeric antigen receptor T-cell therapy
Sarah Kator, Jessica Zurko, Brandon J Webb, et al.
Leukemia Research
|
June 11, 2013
Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomes
Alexander E Sherman, Gabriela Motyckova, K Rebecca Fega, et al.
Molecular Immunology
|
August 13, 2005
Glucocorticoid inhibits the human pro-interleukin lbeta gene (ILIB) by decreasing DNA binding of transactivators to the signal-responsive enhancer
Wayne R Waterman, Li Lian Xu, Sotirios Tetradis, et al.
Leukemia & Lymphoma
|
April 7, 2010
Characteristics and outcomes after autologous stem cell transplant for patients with relapsed or refractory diffuse large B-cell lymphoma who failed initial rituximab, cyclophosphamide, adriamycin, vincristine, and prednisone therapy compared to patients who failed cyclophosphamide, adriamycin, vincristine, and prednisone
Yi-Bin Chen, Ephraim P Hochberg, Yang Feng, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
American Journal of Hematology
|
May 20, 2011
Laboratory testing for cryoglobulins
Gabriela Motyckova, Mandakolathur Murali
Hematology/Oncology Clinics of North America
|
April 3, 2012
Why does my patient have lymphadenopathy or splenomegaly?
Gabriela Motyckova, David P Steensma
Current Treatment Options in Oncology
|
September 9, 2011
Treatment of elderly acute myeloid leukemia patients
Gabriela Motyckova, Richard M Stone
Current Molecular Medicine
|
July 20, 2002
Pycnodysostosis: role and regulation of cathepsin K in osteoclast function and human disease
Gabriela Motyckova, David E Fisher
Current Hematologic Malignancy Reports
|
April 29, 2010
The role of molecular tests in acute myelogenous leukemia treatment decisions
Gabriela Motyckova, Richard M Stone
Infection Control and Hospital Epidemiology
|
July 21, 2017
Decrease in Vancomycin-Resistant Enterococcus Colonization After Extensive Renovation of a Unit Dedicated to the Treatment of Hematologic Malignancies and Hematopoietic Stem-Cell Transplantation
Clyde D Ford, Michaela A Gazdik Stofer, Jana Coombs, et al.
British Journal of Haematology
|
January 21, 2020
Disseminated toxoplasmosis and haemophagocytic lymphohistiocytosis following chimeric antigen receptor T-cell therapy
Sarah Kator, Jessica Zurko, Brandon J Webb, et al.
Leukemia Research
|
June 11, 2013
Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomes
Alexander E Sherman, Gabriela Motyckova, K Rebecca Fega, et al.
Molecular Immunology
|
August 13, 2005
Glucocorticoid inhibits the human pro-interleukin lbeta gene (ILIB) by decreasing DNA binding of transactivators to the signal-responsive enhancer
Wayne R Waterman, Li Lian Xu, Sotirios Tetradis, et al.
Leukemia & Lymphoma
|
April 7, 2010
Characteristics and outcomes after autologous stem cell transplant for patients with relapsed or refractory diffuse large B-cell lymphoma who failed initial rituximab, cyclophosphamide, adriamycin, vincristine, and prednisone therapy compared to patients who failed cyclophosphamide, adriamycin, vincristine, and prednisone
Yi-Bin Chen, Ephraim P Hochberg, Yang Feng, et al.
Page
of 2